Pilgrim Partners Asia Pte LTD Charles River Laboratories International, Inc. Transaction History
Pilgrim Partners Asia Pte LTD
- $115 Billion
- Q4 2024
A detailed history of Pilgrim Partners Asia Pte LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pilgrim Partners Asia Pte LTD holds 260 shares of CRL stock, worth $40,040. This represents 0.04% of its overall portfolio holdings.
Number of Shares
260Holding current value
$40,040% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$948 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$784 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$628 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$328 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$299 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.83B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...